A new market research report by Transparency Market Research, titled “Polycystic Ovarian Syndrome (PCOS) Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, presents an extensive evaluation of this market both in terms of volume and revenue. The competition within the market has been assessed by employing the Porter’s five forces model. The study also presents an in-depth analysis of the governing factors, macro-economic indicators, and the prevailing market trends. The market attractiveness of all segments within the market for PCOS therapeutics has also been presented.

Browse Full Report:http://www.transparencymarketresearch.com/pcos-therapeutics-market.html

Polycystic ovarian syndrome (PCOS) is a type of endocrine system disorder common amongst females between the age of 18 and 44 years. PCOS comprises a set of symptoms caused owing to the elevated male hormone testosterone within women. Symptoms and signs of PCOS comprise heavy, irregular, or no menstruation; excess hair on body or face; acne; pelvic pain; difficulty in conceiving; velvety skin, among others. PCOS can be caused owing to a number of environmental and genetic factors. The market for PCOS therapeutics is segmented into contraceptive drugs, anti-androgen drugs, ovulation stimulants, diabetes treatment drugs, dietary supplements, and cancer treatment drugs.

According to the report, the market for PCOS therapeutics is growing owing to a number of factors. Some of the major factors driving the growth of the market include the rising occurrence of diabetes, the rising hormonal and genetic disorders, and the increasing obese population. Amongst these, PCOS is most common in obese and diabetic women. Furthermore, the increasing count of drugs in clinical trials and their expected commercialization in the coming years will also propel the growth of the market, as per this study.

On the other hand, the increasing penetration of generic and off-label drugs in PCOS therapeutics may inhibit the development of the market. However, the failure of off-label drugs to show the desired results has led to an increased demand for branded drugs for the treatment of PCOS, thus bringing new opportunities for the growth of the market.

In terms of geography, the report segments the market into Europe, North America, Asia Pacific, and Rest of the World (RoW). Amongst these, North America leads the market for PCOS therapeutics and is trailed by Europe. This is owing to the soaring count of women having PCOS within this region resulting in increased diagnosis. On the other hand, Asia Pacific is predicted to exhibit the greatest growth rate in the market for PCOS therapeutics owing to the improving economic conditions and the growing awareness about gynecological healthcare here.

Download Report Brochure For Industry Details:http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1870

As per the report, the prominent players in the market are Crinetics Pharmaceuticals, Inc., Biocinese, Catalysis, S.L., AstraZeneca plc., Eugonia, EffRx, Inc., Ferring Pharmaceuticals, Inc., Merck KGaA, Neurocrine Biosciences, Inc., and Shire plc., and Reliance Life Sciences Pvt. Ltd., among others.